ArticleJournal of contemporary brachytherapy2022

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies.

Naoya Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.